References for Anex Bulletin Volume 8, Edition 2, November 2009. COSMPOLITAN COCKTAILS * Not her real name. 1 Tönne, U, Hiltunen, A. J, Engelbrektsson, K, Björvell, H, Vikander, B, Borg, S (1998): Personality characteristics in primary benzodiazepine-dependent patients: Comparison with controls and polydrug users. Personality and Individual Differences Vol 24: 6 pp7978-804. 2 Frances R, Miller S, Mack A (eds), (2005) Clinical Textbook of Addictive Disorders Third Edition, NY, The Guilford Press, p 247 3 Ministerial Council on Drugs Strategy (2004) The National Drug Strategy: Australia s Integrated Framework 2004 2009, p. 15. 4 Ives, R, Ghelani, P, (2006) Polydrug use (the use of drugs in combination): A brief review Drugs: Education, Prevention & Policy, Volume 13, Number 3, June, p. 225 5 J. Stafford, N. Sindicich, L. Burns, J. Cassar, S. Cogger, B. de Graaff, J. George, C. Moon, B. Phillips, B. Quinn & N. White- Australian Drug Trends 2008: Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 19, NDARC, UNSW, p. 200. 6 Ministerial Council on Drug Strategy, National Drug Strategy 2004 2009. Commonwealth of Australia. Available from: http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/content/5eaed7 7A78166EB5CA2575B4001353A4/$File/framework0409.pdf. Accessed 9. 7 Australian Institute of Health and Welfare 2008. Alcohol and other drug treatment services in Australia 2006 07: report on the National Minimum Data Set. Drug treatment series no. 8. Cat. no. HSE 59. Canberra: AIHW, p. 17. 8 Dobbin M (2009) Interviewed by Anex 8/09/09 by Nicola Cowling. 9 Wodak, A (2009) Concern aired over oxycodone black market, ABC Online, Lateline, Journalist Leigh Sales accessed at http://www.abc.net.au/lateline/content/2008/s2661133.htm [Accessed 10 August 2009]. 10 S. O Brien, E. Black, L. Degenhardt, A. Roxburgh, G. Campbell, B. de Graaff, J. Fetherston, R. Jenkinson, S. Kinner, C. Moon and N. White: (2007) Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Monograph 60. Sydney, National Drug and Alcohol Research Centre, University of New South Wales. 11 Australian Institute of Health and Welfare 2008. 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20.Cat. no. PHE 98. Canberra: AIHW. 12 J. Stafford, N. Sindicich, L. Burns, J. Cassar, S. Cogger, B. de Graaff, J. George, C. Moon, B. Phillips, B. Quinn & N. White. Australian Drug Trends 2008 Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 19, NDARC, UNSW. p. 201 13 Kelly B, Parsons J, (2008) Predictors and Comparisons of Polydrug and Non-Polydrug Cocaine Use in Club Subcultures, The American Journal of Drug and Alcohol Abuse, Volume 34, Issue 6 November, p. 774 14 J. Stafford, N. Sindicich, L. Burns, J. Cassar, S. Cogger, B. de Graaff, J. George, C. Moon, B. Phillips, B. Quinn & N. White. Australian Drug Trends 2008 Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 19, NDARC, UNSW p. 203.
15 Black E, Dunn M, et al, (2008) Australian Trends In Ecstasy and Related Drug Markets 2007: Findings from the Ecstasy and Related Drugs Reporting System (EDRS) Australian Drug Trends Series No. 10, NDARC, UNSW p. 156 16 Black E, Dunn M, et al, (2008) Australian Trends In Ecstasy and Related Drug Markets 2007: Findings from the Ecstasy and Related Drugs Reporting System (EDRS) Australian Drug Trends Series No. 10, NDARC, UNSW p. 195 17 J. Stafford, N. Sindicich, L. Burns, J. Cassar, S. Cogger, B. de Graaff, J. George, C. Moon, B. Phillips, B. Quinn & N. White. Australian Drug Trends 2008 Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 19, NDARC, UNSW p. 199 18 Victorian GovernmentDepartment of Human Services Melbourne (2006). Improving health, reducing harm Victorian Drug Strategy 2006-09. Victoria Department of Human Services 19 ACT Department of Health 2004. Alcohol, Tobacco and other Drug Strategy 2004 2008. Available from: http://health.act.gov.au/c/health?a=dlpol&policy=1150856381 accessed 08/09/09. When DIY is no renovation Reference: http://www.abc.net.au/news...; http://naturalhealthdirect.comau/health/self-test- 129/drug-saliva-test-kit-1363.html New headaches in herbal highs Reference: http://www.news.com.au/perthnow/story/0,21598,25867173-5005370,00.html Mounting Anxiety over Xanax Reference: http://www.themercury.com.au/article/2009/09/04/95181 Feedback from the front line information is paramount 1 Cogger, Shelley; The Early Identification of Drug Harms Project, Bimonthly Report, April May 2009, Turning Point, p4 A Script for Disaster
1 Stafford J, Sindicich N et al., Australian Drug Trends 2008 Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No. 19, NDARC, UNSW, p. 200. 2 Risser, D. & Schneider, B. (1994) Drug-related deaths between 1985 and 1992 examined at the Institute of Forensic Medicine in Vienna, Austria, Addiction, 89, 851-857 3 Downey KK, Helmus T, Schuster CR. Treatment of heroin dependent poly-drug abusers with contingency management and buprenorphine maintenance. Experimental and Clinical Psychopharmacology, 8:176-184, 2000. 4 Burns J, Martyres R, Clode D, Boldero J, 2004, Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances. 5 Nielsen S, Dietze P, Cantwell K, Lee N, Taylor DA. Methadone and Buprenorphine related ambulance attendances: A population-based indicator of adverse events. Journal of Substance Abuse Treatment (2008); 35:457-461. 6 Hall A J; Logan J E; Toblin R; Kaplan J A; Kraner J C; Bixler D; Crosby, A E and. Paulozzi A J. Overdose Fatalities Patterns of Abuse Among Unintentional Pharmaceutical Overdose ; JAMA. (2008);300(22):2613-2620 7 Degenhardt, L., Black, E., Breen, C., Bruno, R., Kinner, S., Roxburgh, A., Fry, C., Jenkinson, R., Ward, J., Fetherston, J., Weekley, J., & Fischer, J. (2006). Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug and Alcohol Review, 25, 403-412. 8 Roche, AM; Guray C; Saunders J B. General practitioners experiences of patients with drug and alcohol problems. Br J Addict (1991); 86: 263-275 9 Bendtsen P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain (1999); 82: 89-96 10 Burns J, Martyres R, Clode D, Boldero J (2004), Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances 11 Gossop, M. (2001). A web of dependence. Addiction, 96, 677 678. Alcohol The common denominator in substance abuse Risk added to the mix 1 Australian Institute of Health and Welfare, 2008 Alcohol and Other Drug Treatment Services in Australia Report on the National Minimum Data Set, AIHW, Canberra, p. 19. Alcoholic Liver Disease Mortality Rates 1 Thomson, S J; Westlake, S; Rahman T M; Cowan, M L; Majeed, A; Maxwell J D; and Kang, J Y; 2008. Chronic Liver Disease An Increasing Problem: A Study of Hospital Admission and Mortality Rates in England, 1979 2005, with Particular Reference to Alcoholic Liver Disease in Alcohol and Alcholism Vol 43, No 4, pp. 416 422. 2 Australian Institute of Health and Welfare 2008. 2007 National Drug Strategy Household Survey: detailed findings. Drug statistics series no. 22. Cat. no. PHE 107. Canberra: AIHW.http://www.aihw.gov.au/publications/phe/ndshs07-df/ndshs07-df.pdf, p. 30.
Sextasy A dangerous blend 1 http://www.viagra.com/about-viagra-ed-treatment.aspx. Accessed 9. 2 Karlovsky, M., Lebed, B. and Mydlo, J.H. 2004. Increasing incidence and importance of HIV/AIDS and gonorrhea among men aged >/= 50 years in the US in erectile dysfunction therapy. Scandinavian Journal of Urology and Nephrology, 38(3), 247-252. 3 Copeland J.; Dillon P. & Gascoigne M. 2004. Ecstasy and the Concomitant Use of Pharmaceuticals NDARC Technical Report No. 201; p. 12. Available from: http://ndarc.med.unsw.edu.au/ndarcweb.nsf/resources/tr_38/$file/tr.201.pdf, [Accessed 7 ]. 4 Copeland J.; Dillon P. & Gascoigne M. 2004. Ecstasy and the Concomitant Use of Pharmaceuticals NDARC Technical Report No. 201; p. 12. Available from: http://ndarc.med.unsw.edu.au/ndarcweb.nsf/resources/tr_38/$file/tr.201.pdf, [Accessed 7 ]. 5 http://www.viagra.com/. Accessed 9. Steroids - Does my bum look big in this? 1 National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2004-2008. National Centre in HIV Epidemiology and Clinical Research, The University of New South 4ales, Sydney, NSW. 2009 2 Fife-Yeomans. J (2009) Steroids spreading in Sydney, The Daily Telegraph, August 31 2009, http://www.dailytelegraph.com.au/news/steroids-spreading-in-sydney/story-e6freuy9-1225767689373 3 Better Health (2009) Steroid Fact Sheet, 4 Bonetta. L (2004) The Steroid Story, American School Board Journal, Vol. 191, no. 8, pp. 19-21; - Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 5 Bonetta. L (2004) The Steroid Story, American School Board Journal, Vol. 191, no. 8, pp. 19-21 6 Better Health (2009) Steroid Fact Sheet, 7 Better Health (2009) Steroid Fact Sheet,
8 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 9 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 10 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 11 Peters. R, Dillion. P & Copeland. J, Steroid Facts, NDARC,UNSW. 12 Bonetta. L (2004) The Steroid Story, American School Board Journal, Vol. 191, no. 8, pp. 19-21; - Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The Exchange, Manly and Northern Sydney Area Health Service (NSAHS); - Lenehan. P & Miller. T (2004) Anabolic Steroids: A guide for users & professionals, produced by Lifeline UK, www.lifelinepublications.org.uk. 13 Lenehan. P & Miller. T (2004) Anabolic Steroids: A guide for users & professionals, produced by Lifeline UK, www.lifelinepublications.org.uk 14 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 15 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 16 Department of Human Services (DHS) (2009) Steroid facts, http://www.dhs.vic.gov.au/neapp/steroids.htm. 17 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The - Department of Human Services (DHS) (2009) Steroid facts, http://www.dhs.vic.gov.au/neapp/steroids.htm. 18 Bonetta. L (2004) The Steroid Story, American School Board Journal, Vol. 191, no. 8, pp. 19-21 19 Better Health (2009) Steroid Fact Sheet, - Department of Human Services (DHS) (2009) Steroid facts, http://www.dhs.vic.gov.au/neapp/steroids.htm. 20 Bonetta. L (2004) The Steroid Story, American School Board Journal, Vol. 191, no. 8, pp. 19-21. 21 Better Health (2009) Steroid Fact Sheet,
22 Better Health (2009) Steroid Fact Sheet, 23 Better Health (2009) Steroid Fact Sheet, 24 Better Health (2009) Steroid Fact Sheet, 25 Better Health (2009) Steroid Fact Sheet, 26 Stathis. H, The Big Book: An overview of Anabolic-Androgenic Steroids, complied for The 27 Better Health (2009) Steroid Fact Sheet, Trouble in the Cupboard 1 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients, - Drugs and Crime Prevention Committee. Inquiry into misuse/abuse of benzodiazepines and other pharmaceutical drugs Interim Report, Melbourne 2006. http://www.parliament.vic.gov.au/dcpc/current_inquiries/pharmaceuticalmisuse/dcpc- Report_Benzo_2006-08-24.pdf Accessed 2 Australian Institute of Health and Welfare 2008. 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20.Cat. no. PHE 98. Canberra: AIHW 3 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients, 4 Black E, Roxburgh A, Degenhardt L, Bruno R, Campbell G, de Graff et. al. Australian drug trends 2007: Findings from the Illicit Drug Reporting System (IDRS), Australian drug trends Series No. 1, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney 2008. 5 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients, - Drugs and Crime Prevention Committee. Inquiry into misuse/abuse of benzodiazepines and other pharmaceutical drugs Interim Report, Melbourne 2006. http://www.parliament.vic.gov.au/dcpc/current_inquiries/pharmaceuticalmisuse/dcpc- Report_Benzo_2006-08-24.pdf Accessed.
6 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients,. 7 The Royal Australasian College of Physicians. Prescription Opioid Policy: Improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use, Sydney 2009. 8 ABC Online, Lateline, 10 August 2009 http://www.abc.net.au/lateline/content/2008/s2661133.htm Accessed 9 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients,. 10 Darke S, Topp L and Ross J (2002) The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug and Alcohol Review 21:27-32. 11 Angela Dean (2006). Drug Interactions Illicit drugs and drug interactions. Australian Pharmacist 25:9 Volume 25 12 Angela Dean (2006). Drug Interactions Illicit drugs and drug interactions. Australian Pharmacist 25:9 Volume 25 13 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients, - The Royal Australasian College of Physicians. Prescription Opioid Policy: Improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use, Sydney 2009. 14 Turning Point. Investigation of pharmaceutical misuse amongst drug treatment clients, - The Royal Australasian College of Physicians. Prescription Opioid Policy: Improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use, Sydney 2009. Half Life Is Worse Than None 1 Fitzroy Legal. What causes a drug overdose?
http://www.fitzroy-legal.org.au/files/services%20directory%202007/ch3- WhatCausesADrugOverdose.pdf Accessed 2 Birkett, D.J. Pharmacokinetics made easy, half-life,australian Prescriber, 11:31988 http://www.library.uq.edu.au/library.uq/gmc/images/gmc015.pdf Accessed 3 Fitzroy Legal. What causes a drug overdose? http://www.fitzroy-legal.org.au/files/services%20directory%202007/ch3- WhatCausesADrugOverdose.pdf Accessed - Dorevitch Pathology P/L. Heidelberg, Victoria 4 Dorevitch Pathology P/L. Heidelberg, Victoria 5 Dorevitch Pathology P/L. Heidelberg, Victoria 6 Department of Human Services. Heroin Overdose Prevention Campaign http://www.health.vic.gov.au/drugs/heroin/ Accessed 7 Department of Human Services. Heroin Overdose Prevention Campaign http://www.health.vic.gov.au/drugs/heroin/ Accessed 8 Department of Human Services. Heroin Overdose Prevention Campaign http://www.health.vic.gov.au/drugs/heroin/ Accessed 9 See: http://www.inchem.org/documents/pims/pharm/pim934.htm 10 See: http://www.inchem.org/documents/pims/pharm/pim934.htm